ConductScience.org, home

Paper7794776

Dapsone for refractory chronic idiopathic thrombocytopenic purpura.

Hernández F and 6 others. Br J Haematol, 1995. Cited by 56 papers, by iCite.

Cite this record

ConductScience Library. Dapsone for refractory chronic idiopathic thrombocytopenic purpura. Papers, record 7794776. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7794776

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Dapsone for refractory chronic idiopathic thrombocytopenic purpura.
PubMed
Journal
Br J Haematol
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
2.17
iCite
Revised in PubMed
2019-07-05
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hernández FF
2Linares MM
3Colomina PP
4Pastor EE
5Cerveró AA
6Pérez AA
7Perella MM

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DapsoneMajor topic
Purpura, Thrombocytopenic, IdiopathicMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Chronic Disease
Female
Humans
Middle Aged
Recurrence
Treatment Outcome

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02627417Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune ThrombocytopeniaBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
31862814Is dapsone still relevant in immune thrombocytopenia in resource limited settings?BMJ Case Rep2019https://conductscience.org/library/papers/31862814PubMed
30057974Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018.Hematol Transfus Cell Ther2018https://conductscience.org/library/papers/30057974PubMed
29084292Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.PLoS One2017https://conductscience.org/library/papers/29084292PubMed
28906353Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura: A PRISMA-compliant systematic review and meta-analysis of 28 studies.Medicine (Baltimore)2017https://conductscience.org/library/papers/28906353PubMed
28698844Dapsone therapy for refractory immune thrombocytopenia patients: a case series.Blood Res2017https://conductscience.org/library/papers/28698844PubMed
28286634The Efficacy of Colchicine and Dapsone Combination Therapy in Relapsed Immune Thrombocytopenia.Hematol Rep2017https://conductscience.org/library/papers/28286634PubMed
26499177Current Management of Primary Immune Thrombocytopenia.Adv Ther2015https://conductscience.org/library/papers/26499177PubMed
23556122Eltrombopag, a thrombopoietin- receptor agonist in the treatment of adult chronic immune thrombocytopenia: a review of the efficacy and safety profile.Ther Adv Hematol2012https://conductscience.org/library/papers/23556122PubMed
21042569Long-term management of chronic immune thrombocytopenic purpura in adults.Int J Gen Med2010https://conductscience.org/library/papers/21042569PubMed
15230645Dapsone therapy for malaria during pregnancy: maternal and fetal outcomes.Drug Saf2004https://conductscience.org/library/papers/15230645PubMed
10024838[Chronic idiopathic thrombocytopenic purpura. Current therapy concept and introduction to pathophysiologic, clinical and diagnostic aspects].Med Klin (Munich)1998https://conductscience.org/library/papers/10024838PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7794776

GET https://conductscience.org/api/papers/v1/7794776/authors